Clinical trials: Chronic Central Serous Chorioretinopathy
Central Serous Chorioretinopathy
Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
The aim of the study is to determine the efficacy and safety in treating patients with chronic central serous chorioretinopathy with the drug eplerenone.
- Trial name
- NCT02153125
- Testing
- Eplerenone
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
Central Serous Chorioretinopathy
The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
The pathophysiology of central serous chorioretinopathy remains controversial. traditional treatment is laser photocoagulation or photodynamic therapy.Recently Bevacizumab (Avastin, Genetech),an antibody to vascular endothelial…
- Trial name
- NCT00864773
- Testing
- intravitreal injection with anterior paracentesis
- Volunteers
- 10 people
- Sponsor
- Hallym University Medical Center
Central Serous Chorioretinopathy
Eplerenone for the Treatment of Central Serous Chorioretinopathy
To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .
- Trial name
- NCT01990677
- Testing
- 25mg Eplerenone
- Where
- 10 sites in United States
- Volunteers
- 108 people
- Sponsor
- Wills Eye
the Presence of Subretinal Fluid (SRF)
Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy.
Chronic Central Serous Chorioretinopathy (CSCR) is a vision-threatening retinal disorder characterized by persistent subretinal fluid due to choroidal vascular hyperpermeability and retinal pigment epithelium (RPE) dysfunction.
- Trial name
- NCT07020793
- Testing
- green subthreshold laser therapy
- Where
- Italy
- Volunteers
- 12 people
- Sponsor
- Federico II University
Chronic Central Serous Chorioretinopathy
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
The purpose of this study is to compare the efficacy and safety of intravitreal ranibizumab injection versus low-fluence PDT in the treatment of chronic CSC.
- Trial name
- NCT01325181
- Testing
- Verteporfin, ranibizumab
- Where
- South Korea
- Volunteers
- 34 people
- Sponsor
- Jang Won Heo
Chronic Central Serous Chorioretinopathy
Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
Chronic central serous chorioretinopathy (CSC) is a relatively frequent eye disease that often occurs in patients in the professionally active age range.
- Trial name
- PLACE (NCT01797861)
- Testing
- Half-dose photodynamic therapy (PDT), Micropulse laser (ML) treatment
- Where
- 5 sites in France, Germany and 2 more
- Volunteers
- 140 people
- Sponsor
- Radboud University Medical Center
Retinal Disease
Finasteride for Chronic Central Serous Chorioretinopathy
Background: Central serous chorioretinopathy (CSC) is a disease that causes fluid to collect under the retina. It affects the macula, which is in the center of the retina and is needed for sharp, clear vision.
- Trial name
- NCT01585441
- Testing
- Finasteride
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- National Eye Institute (NEI)
Central Serous Chorioretinopathy
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.
- Trial name
- NCT00803517
- Where
- South Korea
- Volunteers
- 24 people
- Sponsor
- Samsung Medical Center
Chronic Central Serous Chorioretinopathy
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
- Trial name
- CSC-AA (NCT00489840)
- Testing
- Anecortave Acetate Sterile suspension 15 mg, Anecortave Acetate
- Where
- 2 sites in United States
- Volunteers
- 5 people
- Sponsor
- Manhattan Eye, Ear & Throat Hospital
Chronic Central Serous Chorioretinopathy
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.
- Trial name
- NCT02462499
- Testing
- Inspra (eplerenone)
- Where
- Hungary
- Volunteers
- 28 people
- Sponsor
- Semmelweis University
Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy
Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma
Purpose: To investigate the efficacy of combined use of retinal repetitive electromagnetic stimulation and subtenon autologous platelet-rich plasma in the treatment of recalcitrant or unresponsive chronic central serous…
- Trial name
- CSCR (NCT04224831)
- Testing
- Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis
- Where
- Turkey (Türkiye)
- Volunteers
- 22 people
- Sponsor
- Ankara Universitesi Teknokent